4829 |
Treatment Strategies for Coronary Bifurcation Lesions |
Sung wook Kim |
Apr. 19. 24 |
4828 |
Physiology-guided Optimal PCI: Learning from DEFINE Trials |
Mitsuaki Matsumura |
Apr. 19. 24 |
4827 |
What Events Happened in the Physiology Field in 2023? |
Sang Min Park |
Apr. 19. 24 |
4826 |
What Events Happened in the Imaging Field in 2023? |
Do Hyung Lim |
Apr. 19. 24 |
4825 |
New Concept of Dyslipidemia Medication: The Lower, The Smaller |
Ji Hyun Kim |
Apr. 19. 24 |
4824 |
FDC Management of Hypertension and Dyslipidemia |
Jin Joo Park |
Apr. 19. 24 |
4823 |
Alirocumab and Reduction of Cardiovascular Events: Current Evidence and Future Perspectives |
Hyuck Jun Yoon |
Apr. 19. 24 |
4822 |
Intensive Lipid-Lowering Therapy for Early Achievement of LDL-C Target in Cardiovascular Disease |
Do-Yoon Kang |
Apr. 19. 24 |
4821 |
How Do We Achieve Lower for Longer LDL-C Levels for Patients |
Sang Don Park |
Apr. 19. 24 |
4820 |
What are the Real-world Issue to Keep LDL-C Lower for Longer |
Seok-Jae Hwang |
Apr. 19. 24 |